Cambrios Technologies Corp. Adds Dyax Corp. (DYAX) Phage Display License To Its Genes-To-Electronics Technology Portfolio
10/19/2005 5:12:02 PM
Cambrios Technologies Corp. announced today that the Company has been granted a patent license to Dyax Corp.'s peptide phage display patent portfolio for use in the electronics-industry field, with an option to maintain an exclusive license to these Dyax patents for the synthesis and assembly of materials and structures used in electronic applications. Dyax's proprietary phage display is widely applied in the life sciences industry for therapeutic discovery, diagnostic imaging and other biological applications.
comments powered by